

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 7.66173430 |
| 2 | muscle filament sliding (GO:0030049) | 7.00957635 |
| 3 | actin-myosin filament sliding (GO:0033275) | 7.00957635 |
| 4 | lens morphogenesis in camera-type eye (GO:0002089) | 6.87535988 |
| 5 | skeletal muscle contraction (GO:0003009) | 6.36558946 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.25809621 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 6.25349037 |
| 8 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 6.24641131 |
| 9 | histone H3-K9 demethylation (GO:0033169) | 5.98156130 |
| 10 | ADP metabolic process (GO:0046031) | 5.96745160 |
| 11 | AMP metabolic process (GO:0046033) | 5.91410341 |
| 12 | actin-mediated cell contraction (GO:0070252) | 5.49189512 |
| 13 | visual perception (GO:0007601) | 5.39295513 |
| 14 | sensory perception of light stimulus (GO:0050953) | 5.31460102 |
| 15 | camera-type eye development (GO:0043010) | 5.25115469 |
| 16 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.14932351 |
| 17 | melanin biosynthetic process (GO:0042438) | 5.09461980 |
| 18 | positive regulation of catecholamine secretion (GO:0033605) | 5.06251182 |
| 19 | regulation of oxidative phosphorylation (GO:0002082) | 5.01734710 |
| 20 | regulation of oxidative stress-induced neuron death (GO:1903203) | 4.94334274 |
| 21 | cardiac muscle hypertrophy (GO:0003300) | 4.93895427 |
| 22 | protein refolding (GO:0042026) | 4.91948912 |
| 23 | bile acid and bile salt transport (GO:0015721) | 4.89296818 |
| 24 | skeletal muscle adaptation (GO:0043501) | 4.85959331 |
| 25 | nucleoside diphosphate biosynthetic process (GO:0009133) | 4.82537782 |
| 26 | fructose metabolic process (GO:0006000) | 4.78276720 |
| 27 | melanin metabolic process (GO:0006582) | 4.75944553 |
| 28 | striated muscle hypertrophy (GO:0014897) | 4.68573210 |
| 29 | cellular response to zinc ion (GO:0071294) | 4.59985585 |
| 30 | cytidine catabolic process (GO:0006216) | 4.54398344 |
| 31 | cytidine deamination (GO:0009972) | 4.54398344 |
| 32 | cytidine metabolic process (GO:0046087) | 4.54398344 |
| 33 | polyketide metabolic process (GO:0030638) | 4.53391898 |
| 34 | doxorubicin metabolic process (GO:0044598) | 4.53391898 |
| 35 | daunorubicin metabolic process (GO:0044597) | 4.53391898 |
| 36 | skeletal muscle fiber development (GO:0048741) | 4.40154114 |
| 37 | cardiac muscle contraction (GO:0060048) | 4.34145938 |
| 38 | eye development (GO:0001654) | 4.31908165 |
| 39 | response to mercury ion (GO:0046689) | 4.27661783 |
| 40 | actin filament-based movement (GO:0030048) | 4.27379830 |
| 41 | skeletal muscle tissue development (GO:0007519) | 4.21017021 |
| 42 | cellular response to cadmium ion (GO:0071276) | 4.20512300 |
| 43 | muscle hypertrophy (GO:0014896) | 4.18272915 |
| 44 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.18194048 |
| 45 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.14436340 |
| 46 | plasma membrane repair (GO:0001778) | 4.11267417 |
| 47 | secondary metabolite biosynthetic process (GO:0044550) | 4.07942424 |
| 48 | striated muscle contraction (GO:0006941) | 3.98919695 |
| 49 | carnitine shuttle (GO:0006853) | 3.97905761 |
| 50 | negative regulation of cell size (GO:0045792) | 3.93572269 |
| 51 | regulation of cellular respiration (GO:0043457) | 3.88538612 |
| 52 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.87867130 |
| 53 | adult heart development (GO:0007512) | 3.85415922 |
| 54 | * myofibril assembly (GO:0030239) | 3.80368035 |
| 55 | myotube cell development (GO:0014904) | 3.76432421 |
| 56 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.68450820 |
| 57 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.68450820 |
| 58 | muscle cell fate commitment (GO:0042693) | 3.66759079 |
| 59 | neuromuscular synaptic transmission (GO:0007274) | 3.66121426 |
| 60 | glycogen catabolic process (GO:0005980) | 3.59693309 |
| 61 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.58756815 |
| 62 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.57063601 |
| 63 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.56757445 |
| 64 | regulation of actin filament-based movement (GO:1903115) | 3.56481972 |
| 65 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.54441551 |
| 66 | muscle hypertrophy in response to stress (GO:0003299) | 3.54441551 |
| 67 | cardiac muscle adaptation (GO:0014887) | 3.54441551 |
| 68 | gluconeogenesis (GO:0006094) | 3.54348906 |
| 69 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.53706368 |
| 70 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53085723 |
| 71 | relaxation of muscle (GO:0090075) | 3.50286764 |
| 72 | muscle contraction (GO:0006936) | 3.39857209 |
| 73 | striated muscle cell development (GO:0055002) | 3.36598056 |
| 74 | negative regulation of muscle contraction (GO:0045932) | 3.36203762 |
| 75 | * muscle organ development (GO:0007517) | 3.32754632 |
| 76 | * sarcomere organization (GO:0045214) | 3.32285602 |
| 77 | glucan catabolic process (GO:0009251) | 3.32275218 |
| 78 | hexose biosynthetic process (GO:0019319) | 3.30879135 |
| 79 | * muscle structure development (GO:0061061) | 3.30516476 |
| 80 | NLS-bearing protein import into nucleus (GO:0006607) | 3.29947970 |
| 81 | sensory organ development (GO:0007423) | 3.29221813 |
| 82 | positive regulation of myoblast differentiation (GO:0045663) | 3.26593920 |
| 83 | fatty acid transmembrane transport (GO:1902001) | 3.23135295 |
| 84 | coenzyme catabolic process (GO:0009109) | 3.23012516 |
| 85 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.22760832 |
| 86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.21534313 |
| 87 | creatine metabolic process (GO:0006600) | 3.21235777 |
| 88 | cellular response to toxic substance (GO:0097237) | 3.20602443 |
| 89 | TOR signaling (GO:0031929) | 3.17724455 |
| 90 | * muscle cell cellular homeostasis (GO:0046716) | 3.17724370 |
| 91 | positive regulation of myotube differentiation (GO:0010831) | 3.12629858 |
| 92 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11641228 |
| 93 | skeletal muscle tissue regeneration (GO:0043403) | 3.10273500 |
| 94 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10043362 |
| 95 | regulation of striated muscle contraction (GO:0006942) | 3.10027294 |
| 96 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.09828001 |
| 97 | regulation of Rac protein signal transduction (GO:0035020) | 3.09593309 |
| 98 | cellular polysaccharide catabolic process (GO:0044247) | 3.08133682 |
| 99 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.07723597 |
| 100 | muscle cell development (GO:0055001) | 3.06352331 |
| 101 | mitochondrion degradation (GO:0000422) | 3.04816637 |
| 102 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.03971694 |
| 103 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.03971694 |
| 104 | activation of protein kinase B activity (GO:0032148) | 3.02247494 |
| 105 | positive regulation of chemokine secretion (GO:0090197) | 3.01371089 |
| 106 | striated muscle adaptation (GO:0014888) | 3.01004244 |
| 107 | lens development in camera-type eye (GO:0002088) | 24.5486235 |
| 108 | muscle system process (GO:0003012) | 2.97604651 |
| 109 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96594101 |
| 110 | negative regulation of cell killing (GO:0031342) | 2.96594101 |
| 111 | microglial cell activation (GO:0001774) | 2.95925165 |
| 112 | striated muscle atrophy (GO:0014891) | 2.90454909 |
| 113 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.88502642 |
| 114 | polysaccharide catabolic process (GO:0000272) | 2.85681844 |
| 115 | keratan sulfate catabolic process (GO:0042340) | 2.83142003 |
| 116 | negative regulation of bone remodeling (GO:0046851) | 2.81912752 |
| 117 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.80989094 |
| 118 | negative regulation of tissue remodeling (GO:0034104) | 2.80698467 |
| 119 | negative regulation of granulocyte differentiation (GO:0030853) | 2.78968485 |
| 120 | cardiac myofibril assembly (GO:0055003) | 2.72243523 |
| 121 | regulation of response to osmotic stress (GO:0047484) | 2.69811704 |
| 122 | muscle organ morphogenesis (GO:0048644) | 2.69682827 |
| 123 | regulation of cell communication by electrical coupling (GO:0010649) | 2.68769279 |
| 124 | glucan biosynthetic process (GO:0009250) | 2.67986000 |
| 125 | glycogen biosynthetic process (GO:0005978) | 2.67986000 |
| 126 | regulation of platelet aggregation (GO:0090330) | 2.67927556 |
| 127 | carnitine transmembrane transport (GO:1902603) | 2.65281174 |
| 128 | regulation of sarcomere organization (GO:0060297) | 2.61429563 |
| 129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.61211773 |
| 130 | negative regulation of bone resorption (GO:0045779) | 2.57502245 |
| 131 | response to inactivity (GO:0014854) | 2.55655113 |
| 132 | muscle fiber development (GO:0048747) | 2.54596373 |
| 133 | * actomyosin structure organization (GO:0031032) | 2.52675073 |
| 134 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49867164 |
| 135 | maintenance of protein location in nucleus (GO:0051457) | 2.49504821 |
| 136 | glycogen metabolic process (GO:0005977) | 2.48035697 |
| 137 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47983720 |
| 138 | histone lysine demethylation (GO:0070076) | 2.47469579 |
| 139 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.44240399 |
| 140 | glucan metabolic process (GO:0044042) | 2.41706234 |
| 141 | cellular glucan metabolic process (GO:0006073) | 2.41706234 |
| 142 | * response to muscle activity (GO:0014850) | 2.38621743 |
| 143 | * cellular response to osmotic stress (GO:0071470) | 2.37032651 |
| 144 | purine nucleotide salvage (GO:0032261) | 2.36470259 |
| 145 | muscle atrophy (GO:0014889) | 2.36408147 |
| 146 | muscle adaptation (GO:0043500) | 2.36316954 |
| 147 | regulation of alkaline phosphatase activity (GO:0010692) | 2.36236684 |
| 148 | myotube differentiation (GO:0014902) | 2.36130311 |
| 149 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.35892897 |
| 150 | amino-acid betaine transport (GO:0015838) | 2.35624031 |
| 151 | carnitine transport (GO:0015879) | 2.35624031 |
| 152 | positive regulation of histone deacetylation (GO:0031065) | 2.35003413 |
| 153 | IMP metabolic process (GO:0046040) | 2.34935719 |
| 154 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.34309898 |
| 155 | lens fiber cell development (GO:0070307) | 17.2339984 |
| 156 | lens fiber cell differentiation (GO:0070306) | 14.9651379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.83089359 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.03053201 |
| 3 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.45657409 |
| 4 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 3.32992835 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.11895446 |
| 6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.67263029 |
| 7 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.67263029 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.67263029 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57247396 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.49543771 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.45417766 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34462978 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.26321290 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.16862289 |
| 15 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 2.15760854 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12713050 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.11772253 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04388846 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.90161689 |
| 20 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86844809 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.83890147 |
| 22 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.77705728 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76415840 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75378473 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.75321513 |
| 26 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.74279396 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.73187080 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.72404322 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71416816 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.70673945 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70040528 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.67614240 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.67585815 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67509687 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66040384 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.64223057 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63238117 |
| 38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62081529 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58982862 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58417594 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58014900 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57164528 |
| 43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.56836551 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55930421 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55649483 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53423166 |
| 47 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.50806243 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49635737 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47605175 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46161967 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46074446 |
| 52 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.45153873 |
| 53 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43089382 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42787510 |
| 55 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.38010561 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36939719 |
| 57 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.36547554 |
| 58 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36343786 |
| 59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35916795 |
| 60 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35916795 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34026793 |
| 62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33916331 |
| 63 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.32410483 |
| 64 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.29604231 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29311690 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26027228 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20466026 |
| 68 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.18155630 |
| 69 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.17151589 |
| 70 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.16251651 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15917066 |
| 72 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.15273675 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13624932 |
| 74 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13104921 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12964132 |
| 76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11698581 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11437344 |
| 78 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.09155361 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.09146234 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08765360 |
| 81 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08004592 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07809987 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06764816 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06635697 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06080224 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05817815 |
| 87 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04962947 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04266749 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04030961 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03329344 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02886642 |
| 92 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01616574 |
| 93 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00816931 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99793734 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99685703 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99440469 |
| 97 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98166204 |
| 98 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98160964 |
| 99 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97766255 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97155300 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96932903 |
| 102 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96707534 |
| 103 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96687911 |
| 104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96521607 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95916841 |
| 106 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95828655 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94731447 |
| 108 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94634740 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93264916 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93261334 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92279136 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92123529 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91785509 |
| 114 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.90688421 |
| 115 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90539421 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90511197 |
| 117 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.90368180 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89784579 |
| 119 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89266015 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.89189084 |
| 121 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88883267 |
| 122 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88736912 |
| 123 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88671702 |
| 124 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88539718 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88515722 |
| 126 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88498695 |
| 127 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88073411 |
| 128 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87890490 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87761850 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.87154147 |
| 131 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.87114026 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86716975 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86463615 |
| 134 | MAF_26560356_Chip-Seq_TH2_Human | 0.85780259 |
| 135 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85695798 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85375065 |
| 137 | P68_20966046_ChIP-Seq_HELA_Human | 0.85269769 |
| 138 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.85018040 |
| 139 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84976654 |
| 140 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84943071 |
| 141 | VDR_22108803_ChIP-Seq_LS180_Human | 0.83935434 |
| 142 | UTX_26944678_Chip-Seq_JUKART_Human | 0.83792813 |
| 143 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.81178739 |
| 144 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80604621 |
| 145 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80604621 |
| 146 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80556282 |
| 147 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.78731513 |
| 148 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78512191 |
| 149 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.77333580 |
| 150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76797609 |
| 151 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76636809 |
| 152 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76089539 |
| 153 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75125638 |
| 154 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74879109 |
| 155 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.74203937 |
| 156 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74164757 |
| 157 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.73881014 |
| 158 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73424302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005193_abnormal_anterior_eye | 6.58572819 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 5.25485668 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.87475064 |
| 4 | * MP0000749_muscle_degeneration | 4.40928987 |
| 5 | MP0005451_abnormal_body_composition | 3.53931530 |
| 6 | MP0003646_muscle_fatigue | 3.08302218 |
| 7 | MP0000372_irregular_coat_pigmentation | 3.07305673 |
| 8 | MP0000747_muscle_weakness | 3.05724722 |
| 9 | MP0000751_myopathy | 2.95476101 |
| 10 | MP0002092_abnormal_eye_morphology | 2.92665519 |
| 11 | MP0005253_abnormal_eye_physiology | 2.87010325 |
| 12 | MP0005197_abnormal_uvea_morphology | 2.76129263 |
| 13 | MP0002106_abnormal_muscle_physiology | 2.72306731 |
| 14 | * MP0002269_muscular_atrophy | 2.59815714 |
| 15 | MP0003136_yellow_coat_color | 2.52392662 |
| 16 | MP0001286_abnormal_eye_development | 2.51451352 |
| 17 | MP0005171_absent_coat_pigmentation | 2.47497493 |
| 18 | * MP0000759_abnormal_skeletal_muscle | 2.45903289 |
| 19 | * MP0004087_abnormal_muscle_fiber | 2.28893315 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.20511677 |
| 21 | * MP0005369_muscle_phenotype | 2.11142952 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.05378835 |
| 23 | MP0005391_vision/eye_phenotype | 2.04119757 |
| 24 | MP0002697_abnormal_eye_size | 10.0365839 |
| 25 | MP0000750_abnormal_muscle_regeneration | 1.91474762 |
| 26 | MP0004130_abnormal_muscle_cell | 1.88750392 |
| 27 | MP0005620_abnormal_muscle_contractility | 1.73913168 |
| 28 | MP0002090_abnormal_vision | 1.69310088 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.64212105 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.60764561 |
| 31 | MP0006138_congestive_heart_failure | 1.60680012 |
| 32 | MP0006082_CNS_inflammation | 1.55496404 |
| 33 | MP0004381_abnormal_hair_follicle | 1.54887623 |
| 34 | MP0000733_abnormal_muscle_development | 1.54360047 |
| 35 | MP0003941_abnormal_skin_development | 1.52191959 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.33677914 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.29828740 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.25299891 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.24321058 |
| 40 | MP0009840_abnormal_foam_cell | 1.23896130 |
| 41 | MP0004233_abnormal_muscle_weight | 1.22473518 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.19460133 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.17138934 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.16931327 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.15388479 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.14598750 |
| 47 | MP0005670_abnormal_white_adipose | 1.07304353 |
| 48 | MP0003252_abnormal_bile_duct | 1.05132539 |
| 49 | MP0002254_reproductive_system_inflammat | 1.03352351 |
| 50 | MP0004858_abnormal_nervous_system | 1.01244452 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.00901956 |
| 52 | MP0005408_hypopigmentation | 1.00309064 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.00036748 |
| 54 | MP0001661_extended_life_span | 0.99031707 |
| 55 | MP0003950_abnormal_plasma_membrane | 0.92674753 |
| 56 | MP0003879_abnormal_hair_cell | 0.90587056 |
| 57 | MP0008004_abnormal_stomach_pH | 0.90204280 |
| 58 | MP0001299_abnormal_eye_distance/ | 0.88809742 |
| 59 | MP0008775_abnormal_heart_ventricle | 0.86224690 |
| 60 | MP0006292_abnormal_olfactory_placode | 0.85387095 |
| 61 | MP0001346_abnormal_lacrimal_gland | 0.84166148 |
| 62 | * MP0005330_cardiomyopathy | 0.84025791 |
| 63 | MP0002396_abnormal_hematopoietic_system | 0.81235252 |
| 64 | MP0005257_abnormal_intraocular_pressure | 0.81032736 |
| 65 | MP0005166_decreased_susceptibility_to | 0.79851767 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 0.79561342 |
| 67 | * MP0002108_abnormal_muscle_morphology | 0.76742795 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.75032918 |
| 69 | MP0003075_altered_response_to | 0.74794567 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.73503016 |
| 71 | MP0002925_abnormal_cardiovascular_devel | 0.72323396 |
| 72 | MP0002822_catalepsy | 0.72001137 |
| 73 | MP0004484_altered_response_of | 0.70533644 |
| 74 | MP0002972_abnormal_cardiac_muscle | 0.70444616 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.70293577 |
| 76 | MP0001849_ear_inflammation | 0.69227051 |
| 77 | MP0005266_abnormal_metabolism | 0.68878596 |
| 78 | MP0004270_analgesia | 0.68339036 |
| 79 | MP0005409_darkened_coat_color | 0.67308286 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.66955093 |
| 81 | MP0003045_fibrosis | 0.64815199 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64116831 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.63409551 |
| 84 | MP0005671_abnormal_response_to | 0.63214515 |
| 85 | MP0004272_abnormal_basement_membrane | 0.63012437 |
| 86 | MP0005375_adipose_tissue_phenotype | 0.62906322 |
| 87 | MP0002971_abnormal_brown_adipose | 0.62822665 |
| 88 | MP0000343_altered_response_to | 0.61033176 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.60124537 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.59223449 |
| 91 | MP0004510_myositis | 0.59005002 |
| 92 | * MP0000266_abnormal_heart_morphology | 0.58941114 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.58752530 |
| 94 | MP0002653_abnormal_ependyma_morphology | 0.57530977 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.56381458 |
| 96 | MP0004085_abnormal_heartbeat | 0.54957805 |
| 97 | MP0005187_abnormal_penis_morphology | 0.54764147 |
| 98 | MP0009697_abnormal_copulation | 0.54068133 |
| 99 | MP0000920_abnormal_myelination | 0.53978433 |
| 100 | MP0009672_abnormal_birth_weight | 0.53512611 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.52668203 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.52616242 |
| 103 | MP0005195_abnormal_posterior_eye | 0.52477833 |
| 104 | MP0002928_abnormal_bile_duct | 0.51655329 |
| 105 | MP0003122_maternal_imprinting | 0.51557145 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.50790164 |
| 107 | MP0003828_pulmonary_edema | 0.50498808 |
| 108 | MP0002132_abnormal_respiratory_system | 0.50415244 |
| 109 | MP0005075_abnormal_melanosome_morpholog | 0.50273740 |
| 110 | MP0003787_abnormal_imprinting | 0.49166668 |
| 111 | MP0008770_decreased_survivor_rate | 0.49073934 |
| 112 | MP0000371_diluted_coat_color | 0.48894256 |
| 113 | MP0002088_abnormal_embryonic_growth/wei | 0.48666873 |
| 114 | MP0003315_abnormal_perineum_morphology | 0.48414859 |
| 115 | MP0004134_abnormal_chest_morphology | 0.48373776 |
| 116 | MP0003984_embryonic_growth_retardation | 0.46864429 |
| 117 | MP0001915_intracranial_hemorrhage | 0.45809109 |
| 118 | MP0001614_abnormal_blood_vessel | 0.45647080 |
| 119 | MP0001984_abnormal_olfaction | 0.45557372 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.45046331 |
| 121 | MP0001905_abnormal_dopamine_level | 0.44099209 |
| 122 | MP0009703_decreased_birth_body | 0.44033480 |
| 123 | MP0001544_abnormal_cardiovascular_syste | 0.43828723 |
| 124 | MP0005385_cardiovascular_system_phenoty | 0.43828723 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.43158174 |
| 126 | MP0002078_abnormal_glucose_homeostasis | 0.42120823 |
| 127 | MP0008569_lethality_at_weaning | 0.41833775 |
| 128 | MP0005452_abnormal_adipose_tissue | 0.41501560 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.41457081 |
| 130 | MP0001340_abnormal_eyelid_morphology | 0.40305250 |
| 131 | MP0002128_abnormal_blood_circulation | 0.38667308 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.37832823 |
| 133 | MP0000049_abnormal_middle_ear | 0.37801832 |
| 134 | MP0004197_abnormal_fetal_growth/weight/ | 0.37216104 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.36195753 |
| 136 | MP0001784_abnormal_fluid_regulation | 0.36093611 |
| 137 | MP0002160_abnormal_reproductive_system | 0.35948395 |
| 138 | MP0004215_abnormal_myocardial_fiber | 0.35631532 |
| 139 | MP0005023_abnormal_wound_healing | 0.33367604 |
| 140 | MP0009250_abnormal_appendicular_skeleto | 0.33164465 |
| 141 | MP0001672_abnormal_embryogenesis/_devel | 0.32875391 |
| 142 | MP0005334_abnormal_fat_pad | 0.31233747 |
| 143 | MP0010234_abnormal_vibrissa_follicle | 0.30372287 |
| 144 | MP0003633_abnormal_nervous_system | 0.28938150 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.28894193 |
| 146 | MP0002272_abnormal_nervous_system | 0.26731634 |
| 147 | MP0005165_increased_susceptibility_to | 0.25956870 |
| 148 | MP0009115_abnormal_fat_cell | 0.24068871 |
| 149 | MP0002114_abnormal_axial_skeleton | 0.23757029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital cataract (HP:0000519) | 6.57027789 |
| 2 | Amblyopia (HP:0000646) | 6.18275684 |
| 3 | Corneal dystrophy (HP:0001131) | 5.72070501 |
| 4 | Anterior segment dysgenesis (HP:0007700) | 4.75068019 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 4.66539319 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.42417539 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.29020641 |
| 8 | Nemaline bodies (HP:0003798) | 4.19024013 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 4.17048298 |
| 10 | Polar cataract (HP:0010696) | 3.81464176 |
| 11 | Bulbar palsy (HP:0001283) | 3.61017911 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.37814197 |
| 13 | Limb-girdle muscle atrophy (HP:0003797) | 3.31435938 |
| 14 | Spinal rigidity (HP:0003306) | 3.31113106 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.23019464 |
| 16 | Foot dorsiflexor weakness (HP:0009027) | 3.12347764 |
| 17 | Abnormality of the foot musculature (HP:0001436) | 3.10080387 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.08943695 |
| 19 | Weak cry (HP:0001612) | 3.04461559 |
| 20 | Difficulty running (HP:0009046) | 3.01224109 |
| 21 | Nuclear cataract (HP:0100018) | 23.4460011 |
| 22 | Zonular cataract (HP:0010920) | 20.7711850 |
| 23 | Round ear (HP:0100830) | 2.97721386 |
| 24 | Myopathic facies (HP:0002058) | 2.90299844 |
| 25 | Generalized muscle weakness (HP:0003324) | 2.86746867 |
| 26 | Muscular dystrophy (HP:0003560) | 2.85892763 |
| 27 | Ulnar deviation of the wrist (HP:0003049) | 2.83454569 |
| 28 | Microcornea (HP:0000482) | 2.79249648 |
| 29 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 2.78866547 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 2.74965304 |
| 31 | Dilated cardiomyopathy (HP:0001644) | 2.67250927 |
| 32 | Muscle fiber splitting (HP:0003555) | 2.60078542 |
| 33 | Diaphragmatic weakness (HP:0009113) | 2.55287630 |
| 34 | Bundle branch block (HP:0011710) | 2.54058244 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.53815346 |
| 36 | EMG: myopathic abnormalities (HP:0003458) | 2.49463106 |
| 37 | Resting tremor (HP:0002322) | 2.48222144 |
| 38 | Myoglobinuria (HP:0002913) | 2.46370719 |
| 39 | Iris coloboma (HP:0000612) | 2.46022388 |
| 40 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.40786479 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 2.37652048 |
| 42 | Malignant hyperthermia (HP:0002047) | 2.31624691 |
| 43 | Gowers sign (HP:0003391) | 2.25783211 |
| 44 | Abnormality of the neuromuscular junction (HP:0003398) | 2.22113972 |
| 45 | Fatigable weakness (HP:0003473) | 2.22113972 |
| 46 | Lipoatrophy (HP:0100578) | 2.21089326 |
| 47 | Steppage gait (HP:0003376) | 2.20437747 |
| 48 | Fetal akinesia sequence (HP:0001989) | 2.17176133 |
| 49 | Increased connective tissue (HP:0009025) | 2.14685392 |
| 50 | Muscle stiffness (HP:0003552) | 2.14423545 |
| 51 | Nonprogressive disorder (HP:0003680) | 2.11203172 |
| 52 | Waddling gait (HP:0002515) | 2.09683443 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 2.09379511 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.08890321 |
| 55 | Long clavicles (HP:0000890) | 2.06549965 |
| 56 | Opacification of the corneal stroma (HP:0007759) | 1.98947252 |
| 57 | Rhabdomyolysis (HP:0003201) | 1.89646528 |
| 58 | Abnormality of the anterior chamber (HP:0000593) | 1.88685127 |
| 59 | Postural instability (HP:0002172) | 1.88139038 |
| 60 | Easy fatigability (HP:0003388) | 1.86118678 |
| 61 | Myotonia (HP:0002486) | 1.83709085 |
| 62 | Blue irides (HP:0000635) | 1.82564667 |
| 63 | Deformed tarsal bones (HP:0008119) | 1.82458949 |
| 64 | Ventricular fibrillation (HP:0001663) | 1.82021305 |
| 65 | Absent phalangeal crease (HP:0006109) | 1.81354963 |
| 66 | Abnormality of the calf musculature (HP:0001430) | 1.80880810 |
| 67 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.80118217 |
| 68 | Subaortic stenosis (HP:0001682) | 1.80118217 |
| 69 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78974805 |
| 70 | Rib fusion (HP:0000902) | 1.75106902 |
| 71 | Asymmetric septal hypertrophy (HP:0001670) | 1.73827758 |
| 72 | Hip contracture (HP:0003273) | 1.72800663 |
| 73 | Urinary urgency (HP:0000012) | 1.72675883 |
| 74 | Limb-girdle muscle weakness (HP:0003325) | 1.72209236 |
| 75 | Heart block (HP:0012722) | 1.68480813 |
| 76 | Lower limb amyotrophy (HP:0007210) | 1.68240156 |
| 77 | Difficulty climbing stairs (HP:0003551) | 1.68019687 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 1.67068851 |
| 79 | Nasal speech (HP:0001611) | 1.66508137 |
| 80 | Type 2 muscle fiber atrophy (HP:0003554) | 1.60016153 |
| 81 | Back pain (HP:0003418) | 1.59709013 |
| 82 | Short palpebral fissure (HP:0012745) | 1.58953715 |
| 83 | Abnormal atrioventricular conduction (HP:0005150) | 1.58653761 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 1.58615432 |
| 85 | EMG: neuropathic changes (HP:0003445) | 1.57482712 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 1.57318894 |
| 87 | Neck muscle weakness (HP:0000467) | 1.56786710 |
| 88 | Ventricular tachycardia (HP:0004756) | 1.55968059 |
| 89 | Ventricular arrhythmia (HP:0004308) | 1.54325402 |
| 90 | Sclerocornea (HP:0000647) | 1.52092388 |
| 91 | Rapidly progressive (HP:0003678) | 1.51844116 |
| 92 | Ocular albinism (HP:0001107) | 1.51777304 |
| 93 | Hyperkalemia (HP:0002153) | 1.51691945 |
| 94 | * Proximal amyotrophy (HP:0007126) | 1.51532656 |
| 95 | Popliteal pterygium (HP:0009756) | 1.50391927 |
| 96 | White forelock (HP:0002211) | 1.46543725 |
| 97 | Generalized amyotrophy (HP:0003700) | 1.45717402 |
| 98 | Hepatoblastoma (HP:0002884) | 1.44209685 |
| 99 | Frequent falls (HP:0002359) | 1.44165110 |
| 100 | Distal lower limb muscle weakness (HP:0009053) | 1.43184077 |
| 101 | Ependymoma (HP:0002888) | 1.43020403 |
| 102 | Cerebral aneurysm (HP:0004944) | 1.40979399 |
| 103 | Muscle fiber atrophy (HP:0100295) | 1.40521504 |
| 104 | Achilles tendon contracture (HP:0001771) | 1.40123952 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.38646769 |
| 106 | Posterior subcapsular cataract (HP:0007787) | 1.37560317 |
| 107 | Pelvic girdle muscle weakness (HP:0003749) | 1.35891565 |
| 108 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.35076910 |
| 109 | Areflexia of lower limbs (HP:0002522) | 1.34388752 |
| 110 | Congenital primary aphakia (HP:0007707) | 1.31628450 |
| 111 | Aplasia of the musculature (HP:0100854) | 1.31627528 |
| 112 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.30748394 |
| 113 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.29055850 |
| 114 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.29055850 |
| 115 | Abnormality of the Achilles tendon (HP:0005109) | 1.28408408 |
| 116 | Shoulder girdle muscle weakness (HP:0003547) | 1.26036861 |
| 117 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.25606299 |
| 118 | Rimmed vacuoles (HP:0003805) | 1.23351184 |
| 119 | Neoplasm of the heart (HP:0100544) | 1.21440530 |
| 120 | Fused cervical vertebrae (HP:0002949) | 1.19746523 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.18833336 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.18833336 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 1.18833336 |
| 124 | Urethral obstruction (HP:0000796) | 1.18021973 |
| 125 | Amniotic constriction ring (HP:0009775) | 1.17542915 |
| 126 | Abnormality of placental membranes (HP:0011409) | 1.17542915 |
| 127 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.17487082 |
| 128 | Partial duplication of thumb phalanx (HP:0009944) | 1.17365532 |
| 129 | Dislocated radial head (HP:0003083) | 1.16992442 |
| 130 | Abnormality of the calcaneus (HP:0008364) | 1.16671906 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.15396619 |
| 132 | Ulnar deviation of finger (HP:0009465) | 1.15110788 |
| 133 | Paralysis (HP:0003470) | 1.13926616 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.13455043 |
| 135 | Neonatal respiratory distress (HP:0002643) | 1.12880524 |
| 136 | Glomerulonephritis (HP:0000099) | 1.11979958 |
| 137 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.09758497 |
| 138 | Intestinal fistula (HP:0100819) | 1.08000618 |
| 139 | Abnormality of the radial head (HP:0003995) | 1.06982623 |
| 140 | Slender build (HP:0001533) | 1.06568109 |
| 141 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.06369139 |
| 142 | * Scapular winging (HP:0003691) | 1.05759790 |
| 143 | Bilateral microphthalmos (HP:0007633) | 1.05733674 |
| 144 | Sudden death (HP:0001699) | 1.05443803 |
| 145 | Webbed neck (HP:0000465) | 1.02512260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.46127234 |
| 2 | MAP2K6 | 4.65231284 |
| 3 | TGFBR2 | 4.59618239 |
| 4 | TTN | 3.47702773 |
| 5 | MARK3 | 3.26229332 |
| 6 | CDK12 | 3.18040562 |
| 7 | PHKG2 | 3.08793514 |
| 8 | PHKG1 | 3.08793514 |
| 9 | CSF1R | 2.85221466 |
| 10 | PIK3CG | 2.42362391 |
| 11 | MAP3K7 | 2.22230318 |
| 12 | ERN1 | 2.07637981 |
| 13 | GRK5 | 2.05241424 |
| 14 | GRK7 | 1.97837151 |
| 15 | BLK | 1.95278421 |
| 16 | MAP2K3 | 1.94031058 |
| 17 | PAK4 | 1.87554291 |
| 18 | MAPK12 | 1.84264811 |
| 19 | NME1 | 1.79709243 |
| 20 | STK10 | 1.76777427 |
| 21 | PKN2 | 1.73599821 |
| 22 | SGK1 | 1.72568579 |
| 23 | MUSK | 1.66616942 |
| 24 | MAP3K13 | 1.61082507 |
| 25 | TRIB3 | 1.55716887 |
| 26 | MAPK15 | 1.52207511 |
| 27 | MAP3K1 | 1.49234058 |
| 28 | MAP3K10 | 1.49095439 |
| 29 | FLT3 | 1.39736459 |
| 30 | MOS | 1.38782070 |
| 31 | GRK6 | 1.32257882 |
| 32 | CAMK1G | 1.27020900 |
| 33 | PRKG1 | 1.21915089 |
| 34 | MAPK7 | 1.21612431 |
| 35 | LATS1 | 1.20406044 |
| 36 | ICK | 1.20347232 |
| 37 | MAP2K4 | 1.16276606 |
| 38 | ZAP70 | 1.12800699 |
| 39 | DMPK | 1.09443134 |
| 40 | ARAF | 1.09120012 |
| 41 | CCNB1 | 1.08603765 |
| 42 | CAMK4 | 1.07802753 |
| 43 | ADRBK2 | 1.06676896 |
| 44 | SIK1 | 1.06502592 |
| 45 | NTRK1 | 1.02118635 |
| 46 | WNK1 | 0.98937586 |
| 47 | IGF1R | 0.90185082 |
| 48 | LATS2 | 0.88130519 |
| 49 | CAMK1D | 0.87210395 |
| 50 | SGK2 | 0.84924655 |
| 51 | TYK2 | 0.84723351 |
| 52 | MAP3K9 | 0.82942328 |
| 53 | MATK | 0.80190500 |
| 54 | SGK223 | 0.77731093 |
| 55 | SGK494 | 0.77731093 |
| 56 | SGK3 | 0.76589425 |
| 57 | MAPK10 | 0.76122857 |
| 58 | PTK6 | 0.73569430 |
| 59 | INSR | 0.72982311 |
| 60 | NEK1 | 0.72341337 |
| 61 | KSR2 | 0.67678164 |
| 62 | TYRO3 | 0.67062095 |
| 63 | NME2 | 0.66878812 |
| 64 | ITK | 0.65740939 |
| 65 | PRKACB | 0.63785536 |
| 66 | MAPKAPK3 | 0.62470559 |
| 67 | PDGFRA | 0.62064578 |
| 68 | TIE1 | 0.61977244 |
| 69 | PTK2B | 0.61215197 |
| 70 | RPS6KB1 | 0.60419345 |
| 71 | ROCK1 | 0.59042392 |
| 72 | CAMK2G | 0.58124298 |
| 73 | RPS6KA3 | 0.56898438 |
| 74 | EEF2K | 0.56246312 |
| 75 | AKT2 | 0.56062817 |
| 76 | PINK1 | 0.55235680 |
| 77 | RIPK1 | 0.54944607 |
| 78 | PDPK1 | 0.54177248 |
| 79 | PRKAA1 | 0.53126011 |
| 80 | CSK | 0.52705997 |
| 81 | GRK1 | 0.50222825 |
| 82 | ERBB2 | 0.49980770 |
| 83 | HCK | 0.49667971 |
| 84 | PAK2 | 0.48683154 |
| 85 | PRKG2 | 0.48633285 |
| 86 | PKN1 | 0.47587338 |
| 87 | SIK2 | 0.45396832 |
| 88 | MAP4K1 | 0.45279667 |
| 89 | CDK6 | 0.45195196 |
| 90 | MARK2 | 0.44703683 |
| 91 | PRKAA2 | 0.43749275 |
| 92 | TTK | 0.43391694 |
| 93 | ROCK2 | 0.42930824 |
| 94 | PDK1 | 0.42471430 |
| 95 | EPHB1 | 0.42293238 |
| 96 | JAK1 | 0.41810033 |
| 97 | PRKCB | 0.41622766 |
| 98 | STK38L | 0.39004452 |
| 99 | RIPK4 | 0.38806571 |
| 100 | MARK1 | 0.36612563 |
| 101 | NEK9 | 0.36505244 |
| 102 | FGFR3 | 0.36157831 |
| 103 | PDK2 | 0.35472007 |
| 104 | STK38 | 0.34061047 |
| 105 | BCKDK | 0.33923410 |
| 106 | CDK3 | 0.32218767 |
| 107 | MAP3K3 | 0.32033610 |
| 108 | HIPK2 | 0.31933248 |
| 109 | MAPK11 | 0.31591350 |
| 110 | PRPF4B | 0.30698594 |
| 111 | JAK2 | 0.30679668 |
| 112 | CAMK2D | 0.30481457 |
| 113 | CAMK1 | 0.29065456 |
| 114 | BMPR1B | 0.28784474 |
| 115 | PRKCQ | 0.28567320 |
| 116 | MAPKAPK2 | 0.28233511 |
| 117 | PTK2 | 0.28108237 |
| 118 | MTOR | 0.27139570 |
| 119 | PRKACG | 0.27082221 |
| 120 | CAMK2B | 0.26522301 |
| 121 | TSSK6 | 0.26155398 |
| 122 | STK11 | 0.26086090 |
| 123 | TBK1 | 0.25779176 |
| 124 | FGR | 0.25092963 |
| 125 | TNK2 | 0.23563705 |
| 126 | PIK3CA | 0.22581515 |
| 127 | ADRBK1 | 0.21782072 |
| 128 | MAP2K7 | 0.21691000 |
| 129 | RPS6KA1 | 0.21572341 |
| 130 | LRRK2 | 0.21436061 |
| 131 | MAP2K1 | 0.21405813 |
| 132 | MAPK13 | 0.21251247 |
| 133 | CSNK1A1L | 0.21008584 |
| 134 | NTRK3 | 0.20501636 |
| 135 | RET | 0.20359720 |
| 136 | MAPK4 | 0.20093657 |
| 137 | IRAK2 | 0.19044957 |
| 138 | CAMK2A | 0.18982876 |
| 139 | SYK | 0.18928288 |
| 140 | LCK | 0.18850184 |
| 141 | TRPM7 | 0.18538823 |
| 142 | BRAF | 0.17798860 |
| 143 | PRKACA | 0.16863764 |
| 144 | PRKD1 | 0.15744702 |
| 145 | PAK1 | 0.15401590 |
| 146 | CDK5 | 0.15068975 |
| 147 | RAF1 | 0.14841220 |
| 148 | MELK | 0.14421178 |
| 149 | DYRK1B | 0.13109849 |
| 150 | WEE1 | 0.12616925 |
| 151 | MAP3K5 | 0.12421408 |
| 152 | CDK14 | 0.12084083 |
| 153 | NEK2 | 0.10777213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.11396348 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.87984343 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.72364833 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.55543348 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.36961487 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.96905264 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.93865825 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.90877374 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90429068 |
| 10 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.85153239 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81694315 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.79190165 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.76412282 |
| 14 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.72199928 |
| 15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.71115277 |
| 16 | Insulin resistance_Homo sapiens_hsa04931 | 1.64204333 |
| 17 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.62350634 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60372291 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56641723 |
| 20 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.53979724 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51884884 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45587067 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45322061 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.40313114 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.38861439 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36719684 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34702355 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.30946906 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.30744894 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.29638228 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.28522949 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27218632 |
| 33 | Mineral absorption_Homo sapiens_hsa04978 | 1.26734227 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22078922 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21153751 |
| 36 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20986519 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20651607 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15338916 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14372230 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13378917 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12016462 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08605607 |
| 43 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.08338854 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08310223 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.06516290 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06444266 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06295933 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04963270 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04076936 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03605557 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.03602380 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03273614 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01081776 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99745234 |
| 55 | Focal adhesion_Homo sapiens_hsa04510 | 0.99182031 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98839054 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.98352451 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96986029 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93414086 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92186454 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91179191 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90765871 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90142401 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89073385 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88405441 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.87659818 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87477160 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85386676 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.84989291 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84898377 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84345920 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83636467 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82507453 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82360522 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82358026 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82324600 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.82235062 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81551358 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81097672 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80371083 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79276137 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77001765 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76381251 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75208638 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74966323 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73582596 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.72992535 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71982758 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71783461 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70413236 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69838185 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69648769 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.68865791 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68741318 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68518154 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66288547 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65581240 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65082535 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.64280874 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.62703628 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62600697 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60097574 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59572157 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59313914 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58265821 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58180912 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57937028 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56820697 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56553468 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.56274942 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56030676 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55220858 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54778033 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.54497054 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53752891 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53729680 |
| 117 | Long-term depression_Homo sapiens_hsa04730 | 0.53549824 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53210531 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51814912 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.51578375 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50971498 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.50772416 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50100080 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49972499 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49705017 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48272469 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47931068 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.47679203 |
| 129 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44518709 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.38867636 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35649886 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34652320 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.33963778 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31269844 |
| 135 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31216820 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31048509 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.31034684 |
| 138 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30121260 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28680647 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28157174 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27340680 |
| 142 | Bile secretion_Homo sapiens_hsa04976 | 0.24568903 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23959667 |
| 144 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.20458952 |
| 145 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19953126 |

